» Articles » PMID: 24423853

A Bias-free, Automated Planning Tool for Technique Comparison in Radiotherapy - Application to Nasopharyngeal Carcinoma Treatments

Overview
Date 2014 Jan 16
PMID 24423853
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

In this study a novel, user-independent automated planning technique was developed to objectively compare volumetric modulated arc therapy (VMAT) and intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma planning, and to determine which technique offers a greater benefit for parotid-sparing and dose escalation strategies. Ten patients were investigated, with a standard prescription of three dose levels to the target volumes (70, 63, and 56 Gy), using a simultaneous integrated boost in 33 fractions. The automated tool was used to investigate three planning strategies with both IMRT and VMAT: clinically acceptable plan creation, parotid dose sparing, and dose escalation. Clinically acceptable plans were achieved for all patients using both techniques. For parotid sparing, automated planning reduced the mean dose to a greater extent using VMAT rather than IMRT (17.0 Gy and 19.6 Gy, respectively, p < 0.01). For dose escalation to the mean of the main clinical target volume, neither VMAT nor IMRT offered a significant benefit over the other. The OAR-limiting prescriptions for VMAT ranged from 84-98 Gy, compared to 76-110 Gy for IMRT. Employing a user-independent planning technique, it was possible to objectively compare VMAT and IMRT for nasopharyngeal carcinoma treatment strategies. VMAT offers a parotid-sparing improvement, but no significant benefit was observed for dose escalation to the primary target.

Citing Articles

Fluence smoothing evaluation for whole-breast automatically generated treatment plans.

Zaratim G, Oliveira E Silva L, Dos Reis R, Mendes C, Gomes M J Appl Clin Med Phys. 2024; 26(2):e14564.

PMID: 39611818 PMC: 11799910. DOI: 10.1002/acm2.14564.


Knowledge-based radiation treatment planning: A data-driven method survey.

Momin S, Fu Y, Lei Y, Roper J, Bradley J, Curran W J Appl Clin Med Phys. 2021; 22(8):16-44.

PMID: 34231970 PMC: 8364264. DOI: 10.1002/acm2.13337.


Personalized setting of plan parameters using feasibility dose volume histogram for auto-planning in Pinnacle system.

Xia W, Han F, Chen J, Miao J, Dai J J Appl Clin Med Phys. 2020; 21(7):119-127.

PMID: 32363757 PMC: 7386185. DOI: 10.1002/acm2.12897.


Artificial Intelligence in Radiotherapy Treatment Planning: Present and Future.

Wang C, Zhu X, Hong J, Zheng D Technol Cancer Res Treat. 2019; 18:1533033819873922.

PMID: 31495281 PMC: 6732844. DOI: 10.1177/1533033819873922.


Individualized automated planning for dose bath reduction in robotic radiosurgery for benign tumors.

Rossi L, Mendez Romero A, Milder M, de Klerck E, Breedveld S, Heijmen B PLoS One. 2019; 14(2):e0210279.

PMID: 30726214 PMC: 6364873. DOI: 10.1371/journal.pone.0210279.


References
1.
Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O . Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results. Int J Radiat Oncol Biol Phys. 2004; 60(2):374-87. DOI: 10.1016/j.ijrobp.2004.03.010. View

2.
Bzdusek K, Friberger H, Eriksson K, Hardemark B, Robinson D, Kaus M . Development and evaluation of an efficient approach to volumetric arc therapy planning. Med Phys. 2009; 36(6):2328-39. DOI: 10.1118/1.3132234. View

3.
Lee T, Chao P, Ting H, Lo S, Wang Y, Tuan C . Comparative analysis of SmartArc-based dual arc volumetric-modulated arc radiotherapy (VMAT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma. J Appl Clin Med Phys. 2011; 12(4):3587. PMC: 5718754. DOI: 10.1120/jacmp.v12i4.3587. View

4.
Yu C, Tang G . Intensity-modulated arc therapy: principles, technologies and clinical implementation. Phys Med Biol. 2011; 56(5):R31-54. DOI: 10.1088/0031-9155/56/5/R01. View

5.
Kam M, Leung S, Zee B, Chau R, Suen J, Mo F . Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol. 2007; 25(31):4873-9. DOI: 10.1200/JCO.2007.11.5501. View